Health
Chinese Covid-19 vaccine also found safe, induces immune response – Hindustan Times
The results, published on Tuesday in The Lancet Infectious Diseases Journal, add to the number of vaccine candidates under trial that have been found safe.
Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) show that the formulation appears safe and induces an antibody response in health volunteers aged 18 to 59 years.
The results, published on Tuesday in The Lancet Infectious Diseases Journal, add to the number of vaccine candidates under trial that have been found safe. The Chinese trial involved more than 700 volunteers recruited in China between April…
Continue Reading
